NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Small Pharma Inc (V: DMT)

 
DMT Technical Analysis
5
As on 9th Jun 2023 DMT STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.19 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DMTSTOCK Price

Open 0.06 Change Price %
High 0.06 1 Day -0.01 -14.29
Low 0.06 1 Week -0.01 -14.29
Close 0.06 1 Month -0.02 -25.00
Volume 61000 1 Year -0.23 -79.31
52 Week High 0.38 | 52 Week Low 0.06
 
V Canada Most Active Stocks
SNV 0.06 100.00%
GDNP 0.14 -17.65%
NOCR 0.02 0.00%
RHC 0.34 0.00%
NHHH 0.10 0.00%
VXTR 0.17 -5.56%
PGM 0.02 0.00%
FOM 3.23 3.86%
NBY 0.08 0.00%
GXU 0.15 0.00%
 
V Canada Top Gainers Stocks
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
 
V Canada Top Losers Stocks
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
VKG-H 0.02 -50.00%
MAP 0.01 -50.00%
MAP 0.01 -50.00%
 
 
DMT
Daily Charts
DMT
Intraday Charts
Whats New @
Bazaartrend
DMT
Free Analysis
 
DMT Important Levels Intraday
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
RESISTANCE0.06
 
DMT Forecast May 2024
4th UP Forecast0.25
3rd UP Forecast0.19
2nd UP Forecast0.15
1st UP Forecast0.11
1st DOWN Forecast0.01
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.07
4th DOWN Forecast-0.13
 
DMT Weekly Forecast
4th UP Forecast0.29
3rd UP Forecast0.22
2nd UP Forecast0.17
1st UP Forecast0.13
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.05
3rd DOWN Forecast-0.10
4th DOWN Forecast-0.17
 
DMT Forecast2024
4th UP Forecast0.72
3rd UP Forecast0.51
2nd UP Forecast0.38
1st UP Forecast0.25
1st DOWN Forecast-0.13
2nd DOWN Forecast-0.26
3rd DOWN Forecast-0.39
4th DOWN Forecast-0.6
 
 
DMT Other Details
Segment EQ
Market Capital 174240000.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
DMT Address
DMT
 
DMT Latest News
 
Your Comments and Response on Small Pharma Inc
 
DMT Business Profile
Small Pharma Inc., a clinical stage neuropharmaceutical company, engages in the IP-led development of novel treatments for depression and other mental health conditions. The company's lead product candidate is SPL026, a N,N-dimethyltryptamine (DMT) assisted therapy that is in Phase I/IIa randomized controlled clinical trial for the treatment of major depressive disorders. Its preclinical product candidates include SPL028 and SPL029 tryptamine analogues to assess and deliver alternative treatment profiles for the treatment of depression and other mental health disorders; and SPL801, an oral formulation of 6 -hydroxynorketamine. The company was founded in 2015 and is headquartered in London, United Kingdom. Address: 6-8 Bonhill Street, London, United Kingdom, EC2A 4BX
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service